PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 76 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 2.62 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $21,000 | 0.0% | 35,327 | +9.1% | 0.00% | – |
| Q1 2017 | $21,000 | +250.0% | 32,387 | +59.5% | 0.00% | – |
| Q4 2016 | $6,000 | -33.3% | 20,307 | 0.0% | 0.00% | – |
| Q3 2016 | $9,000 | -57.1% | 20,307 | -65.2% | 0.00% | – |
| Q2 2016 | $21,000 | +16.7% | 58,416 | +40.2% | 0.00% | – |
| Q1 2016 | $18,000 | -76.0% | 41,660 | -34.3% | 0.00% | – |
| Q4 2015 | $75,000 | +102.7% | 63,445 | +73.3% | 0.00% | – |
| Q3 2015 | $37,000 | -45.6% | 36,600 | -29.8% | 0.00% | – |
| Q2 2015 | $68,000 | -8.1% | 52,100 | -5.3% | 0.00% | – |
| Q1 2015 | $74,000 | -42.6% | 55,011 | -40.4% | 0.00% | – |
| Q4 2014 | $129,000 | – | 92,242 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAXTER BROS INC | 170,506 | $232,000 | 0.09% |
| First Heartland Consultants, Inc. | 86,204 | $117,000 | 0.05% |
| Rotella Capital Management, Inc. | 20,769 | $28,000 | 0.03% |
| FIDGEON TIMOTHY F | 33,000 | $45,000 | 0.02% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 547,800 | $746,000 | 0.02% |
| Freedom Investment Management, Inc. | 74,127 | $101,000 | 0.02% |
| Investors Capital Advisory Services | 63,288 | $86,000 | 0.02% |
| REYNOLDS CAPITAL MANAGEMENT LLC | 10,000 | $14,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 76,914 | $104,000 | 0.01% |
| PINNACLE FINANCIAL PARTNERS INC | 20,000 | $27,000 | 0.01% |